Commentary on Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term follow-up of a randomized clinical trial: Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, and Crawford ED, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

✍ Scribed by Mark A. Ritter

• Book ID: 116956566
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 103 KB
• Volume: 27
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/j.urolonc.2009.04.016